Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -60163.55x is 99% below its 1-year average of -30292.78x, near the low end of its 1-year range (-60163.55x–-422.00x).
As of the fiscal period ended Wednesday, March 31, 2021.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-60163.55x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-1422206.18%
vs the sector median at left
Helus Pharma Inc.
Market Cap
$658.52M
Interest Coverage Ratio
-60163.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$666.85M
Interest Coverage Ratio
35.83x
TTM Avg
47.17x
3Y Avg
33.36x
5Y Avg
33.36x
Market Cap
$683.14M
Interest Coverage Ratio
-696.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$649.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$638.20M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$715.02M
Interest Coverage Ratio
-67.01x
TTM Avg
15.61x
3Y Avg
8.76x
5Y Avg
6.40x
Market Cap
$715.49M
Interest Coverage Ratio
2.27x
TTM Avg
2.29x
3Y Avg
1.77x
5Y Avg
1.65x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Helus Pharma Inc. (HELP) | $658.52M | -60163.55x | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $665.25M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $666.85M | 35.83x | 47.17x | 33.36x | 33.36x |
| Faeth Therapeutics, Inc. (FTH)vs › | $683.14M | -696.50x | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $649.13M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $715.02M | -67.01x | 15.61x | 8.76x | 6.40x |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $715.49M | 2.27x | 2.29x | 1.77x | 1.65x |
| Climb Bio, Inc. (CLYM)vs › | $625.03M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $621.12M | -1214.61x | 176.24x | 176.24x | 176.24x |
Interest Coverage
-60163.6x
Debt/Equity
0.00
Current Ratio
10.97
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-03-31 | -60163.55x |
| 2020-06-30 | -422.00x |
